Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare PBM Restrictions Would Lead To Higher Premiums, CBO Says

Executive Summary

The PBM "transparency" provision in the Senate's Medicare prescription drug bill would lead to higher monthly premiums and higher beneficiary cost-sharing, the Congressional Budget Office said

You may also be interested in...



PBMs Take Aim At Disclosure, Transparency Provisions In House Health Reform Bill

CVS Caremark CEO Tom Ryan predicts during the company's second quarter call that "once CBO scores this, [the transparency provision] will not survive."

PBMs Estimate Costs Of Restrictive Legislation; NCPA Urges “Education”

Legislation requiring PBMs to disclose specific terms of contracts with manufacturers would increase Medicare prescription drug spending by 7%, an analysis commissioned by the Pharmaceutical Care Management Association maintains

PBMs Estimate Costs Of Restrictive Legislation; NCPA Urges “Education”

Legislation requiring PBMs to disclose specific terms of contracts with manufacturers would increase Medicare prescription drug spending by 7%, an analysis commissioned by the Pharmaceutical Care Management Association maintains

Related Content

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel